OrbiMed Advisors »

Bright Minds Biosciences shares owned by OrbiMed Advisors

Quarter-by-quarter ownership of Bright Minds Biosciences (DRUG) shares owned by OrbiMed Advisors from 13F filings

Historical chart of OrbiMed Advisors investment in Bright Minds Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Bright Minds Biosciences held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bright Minds Biosciences by OrbiMed Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.9M 40k 72.97

More positions owned by OrbiMed Advisors

Edgewise Therapeutics (EWTX)
Enliven Therapeutics (ELVN)
Avita Therapeutics (RCEL)
Mdxhealth Sa Shs New Call Option (MDXH)
Eli Lilly & Co. (LLY)
Sinovac Biotech SHS
Boston Scientific Corporation (BSX)
Sionna Therapeutics (SION)
Astrazeneca Ord (AZN)
Myriad Genetics (Principal) (MYGN)
Mbx Biosciences (MBX)
Corvus Pharmaceuticals (CRVS)
Argenx Se Sponsored Adr (ARGX)
Edwards Lifesciences (EW)
Intuitive Surgical Com New (ISRG)

View all positions for OrbiMed Advisors

Top funds holding Bright Minds Biosciences

Henderson Group
Cormorant Asset Management
BlackRock
Vivo Capital
Braidwell
Vestal Point Capital
Adage Capital Partners GP
Perceptive Advisors
Balyasny Asset Management
Deerfield Management Company
Driehaus Capital Management
RA Capital Management
Dr. Jeffrey R. Jay, M.D.
MPM Oncology Impact Management
Ikarian Capital

View all funds holding Bright Minds Biosciences